Why the study?
What kind of cardiac dysfunction do plasma natriuretic peptides (ANP and BNP) represent in patients undergoing chronic hemodialysis?
What kind of cardiac dysfunction do plasma natriuretic peptides (ANP and BNP) represent in patients undergoing chronic hemodialysis?
In hemodialysis patients, BNP is a better indicator of left heart function than ANP, and a BNP/ANP ratio > 5 identifies patients with severe cardiac hypertrophy and systolic dysfunction.
Answers are grounded in this paper and cite their sources.
May flag severe cardiac dysfunction in hemodialysis; hypothesis-generating and needs prospective validation before clinical adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ohashi et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: